Mark G. Foletta - May 18, 2023 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Mark G Foletta
Stock symbol
DXCM
Transactions as of
May 18, 2023
Transactions value $
$3
Form type
4
Date filed
5/22/2023, 03:49 PM
Previous filing
May 19, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $3.31 +3.31K +73.66% $0.00* 7.79K May 18, 2023 Direct F1
transaction DXCM Common Stock Gift $0 -4.49K -57.58% $0.00 3.31K May 18, 2023 Direct F2
transaction DXCM Common Stock Gift $0 +4.49K +8.22% $0.00 59.1K May 18, 2023 by Trust F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units.
F3 Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.